![Carl Magnus Högerkorp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Magnus Högerkorp
Plus aucun poste en cours
Profil
Carl Magnus Högerkorp is the founder of Immodulate Pharma AB, which was founded in 2021.
He held the title of Chief Executive Officer at Immodulate Pharma AB. Dr. Högerkorp also held the position of Chief Executive Officer at CanImGuide Therapeutics AB from 2019 to 2021, at Edvince AB from 2017 to 2018, and at Xintela AB from 2016 to 2017.
He was also the Chief Executive Officer at Cyxone AB from 2022 to 2023.
Dr. Högerkorp obtained a doctorate degree from the University of Lund and an MBA from Lund University School of Economics & Management.
Anciens postes connus de Carl Magnus Högerkorp
| Sociétés | Poste | Fin |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Directeur Général | 01/04/2021 |
Edvince AB
 Edvince AB Miscellaneous Commercial ServicesCommercial Services Engages in scientific and technological research & development activities | Directeur Général | 01/10/2018 |
| XINTELA AB | Directeur Technique/Scientifique/R&D | 01/04/2017 |
Immodulate Pharma AB | Directeur Général | - |
| CYXONE AB | Directeur Général | - |
Formation de Carl Magnus Högerkorp
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Xintela AB
 Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases | Health Technology |
Lund University School of Economics & Management
 Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyxone AB
 Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
Edvince AB
Edvince AB Miscellaneous Commercial ServicesCommercial Services Engages in scientific and technological research & development activities | Commercial Services |
Immodulate Pharma AB |
Choisissez Zonebourse 
